B-ring-modified isocombretastatin A-4 analogues endowed with interesting anticancer activities.
Abdallah Hamze, Evelia Rasolofonjatovo, Olivier Provot, Céline Mousset, Damien Veau, Jordi Rodrigo, Jérôme Bignon, Jian-Miao Liu, Joanna Wdzieczak-Bakala, Sylviane Thoret, Joëlle Dubois, Jean-Daniel Brion, Mouad Alami
Index: ChemMedChem 12th ed., 6 , 2179-2191, (2011)
Full Text: HTML
Abstract
A novel class of isocombretastatin A-4 (isoCA-4) analogues with modifications at the 3'-position of the B-ring by replacement with C-linked substituents was studied. Exploration of the structure-activity relationships of theses analogues led to the identification of several compounds that exhibit excellent antiproliferative activities in the nanomolar concentration range against H1299, MDA-MB231, HCT116, and K562 cancer cell lines; they also inhibit tubulin polymerization with potency similar to that of isoCA-4. 1,1-Diarylethylenes 8 and 17, respectively with (E)-propen-3-ol and propyn-3-ol substituents at the 3'-position of the B-ring, proved to be the most active in this series. Both compounds led to the arrest of various cancer cell lines at the G(2) /M phase of the cell cycle and strongly induced apoptosis. Docking of compounds 8 and 17 in the colchicine binding site indicated that their C3' substituents guide the positioning of the B-ring in a manner different from that observed for isoCA-4.Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Related Compounds
Related Articles:
2012-04-06
[Org. Lett. 7th ed., 14 , 1930-1933, (2012)]
2012-04-07
[Org. Biomol. Chem. 13th ed., 10 , 2683-2691, (2012)]
2012-02-08
[J. Am. Chem. Soc. 5th ed., 134 , 2528-2531, (2012)]
2012-04-06
[J. Org. Chem. 7th ed., 77 , 3518-3523, (2012)]
2011-10-27
[J. Med. Chem. 54 , 7094-7104, (2011)]